Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients

Various immunotherapies for the treatment of type 1 diabetes are currently under investigation. Some of these aim to rescue the remaining beta cells from autoimmune attack caused by the disease. Among the strategies employed, p53 has been envisaged as a possible target for immunomodulation. We studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegrino, Marsha, Traversi, Gianandrea, Arena, Andrea, Cappa, Marco, Rosado, M. Manuela, Andreani, Marco, Delfino, Domenico V., Moretti, Fabiola, Fierabracci, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988923/
https://www.ncbi.nlm.nih.gov/pubmed/31995625
http://dx.doi.org/10.1371/journal.pone.0228296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988923/
https://www.ncbi.nlm.nih.gov/pubmed/31995625
http://dx.doi.org/10.1371/journal.pone.0228296

Ejemplares similares